Rationale and design of the iPap trial: A randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Sultana, Farhana ^a   English, Dallas R ^a,b   Simpson, Julie A ^a   Brotherton, Julia M L ^a,c   Drennan, Kelly ^d   Mullins, Robyn ^b   Heley, Stella ^d   Wrede, C D ^e   Saville, Marion ^d   Gertig, Dorota M ^a,d,f  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c VICTORIAN CYTOLOGY SERVICE   (Australia)

^d VCS Inc   (Australia)

^e ROYAL WOMEN'S HOSPITAL   (Australia)

^f Victorian Cervical Cytology Registry Melbourne   (Australia)

Author keywords

Cervical screening; Home based; HPV DNA testing; Participation; Self sample

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER SCREENING; CONTROLLED STUDY; FEMALE; GYNECOLOGICAL AND OBSTETRIC SAMPLING DEVICE; HOME CARE; HUMAN; HUMAN PAPILLOMAVIRUS SELF SAMPLING KIT; LABORATORY TEST; MANAGED CARE; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PATIENT PARTICIPATION; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STUDY DESIGN;

ADULT; AUSTRALIA; CERVIX UTERI; DIAGNOSTIC SELF EVALUATION; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; SELF CARE; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84899055445     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-207     Document Type: Article

References (38)

1. IARC Working Group on the Evaluation of Cancer Preventive Strategies IARC Handbooks of Cancer Prevention 2005, Lyon: IARC Press, IARC Working Group on the Evaluation of Cancer Preventive Strategies.
2. The Australian Institute of Health and Welfare (AIHW) Cervical screening in Australia 2010-2011 2013, Canberra: AIHW, The Australian Institute of Health and Welfare (AIHW).
3. Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med 2007, 45:93-106. 10.1016/j.ypmed.2007.06.007, 17651792.
4. Victorian Cervical Cytology Registry Statistical Report 2011 2011, Carlton South, Victoria, Australia: Victorian Cytology Service Inc., http://www.vccr.org/stats.html. (Accessed February 2, 2014), Victorian Cervical Cytology Registry.
5. Waller J, Bartoszek M, Marlow L, Wardle J. Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen 2009, 16:199-204. 10.1258/jms.2009.009073, 20054095.
6. McCaffery K, Irwig L. Australian women's needs and preferences for information about human papillomavirus in cervical screening. J Med Screen 2005, 12:134-141. 10.1258/0969141054855238, 16156944.
7. Igidbashian S, Boveri S, Spolti N, Radice D, Sandri MT, Sideri M. Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalities. J Wom Health 2011, 20:397-402.
8. Szarewski A, Cadman L, Ashdown-Barr L, Waller J. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. J Med Screen 2009, 16:193-198. 10.1258/jms.2009.009069, 20054094.
9. Szarewski A, Cadman L, Mallett S, Austin J, Londesborough P, Waller J, Wardle J, Altman DG, Cuzick J. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. J Med Screen 2007, 14:34-42. 10.1258/096914107780154486, 17362570.
10. Day S, Dort P, Tay-Toe K. Knowledge Translation: A review of Strategies to Increase Participation in Cancer Screening 2010, Carlton South, Victoria, Australia: Victorian Cytology Service Inc, http://www.vccr.org/downloads/Vol%203%20Knowledge%20Translation.pdf (Accessed February 2, 2014).
11. Victorian Cervical Cytology Registry Evaluation of Pilot Catch-up of Second Reminders 2013, Carlton South, Victoria, Australia: Victorian Cytology Service Inc., Victorian Cervical Cytology Registry.
12. Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Canc 2002, 2:342-350.
13. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348:518-527. 10.1056/NEJMoa021641, 12571259.
14. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55:244-265. 10.1136/jcp.55.4.244, 1769629, 11919208.
15. Meijer CJLM, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DAM, Snijders PJF. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Canc 2009, 124:516-520.
16. Rijkaart DC, Berkhof J, Rozendaal L, van Kemenade FJ, Bulkmans NW, Heideman DA, Kenter GG, Cuzick J, Snijders PJ, Meijer CJ. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol 2012, 13:78-88. 10.1016/S1470-2045(11)70296-0, 22177579.
17. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Canc 2006, 119:1095-1101.
18. Schmeink CE, Bekkers RLM, Massuger LFAG, Melchers WJG. The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening. Rev Med Virol 2011, 21:139-153. 10.1002/rmv.686, 21538664.
19. Ogilvie GS, Patrick DM, Schulzer M, Sellors JW, Petric M, Chambers K, White R, FitzGerald JM. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect 2005, 81:207-212. 10.1136/sti.2004.011858, 1744976, 15923286.
20. Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlee F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007, 105:530-535. 10.1016/j.ygyno.2007.01.023, 17335880.
21. Stewart DE, Gagliardi A, Johnston M, Howlett R, Barata P, Lewis N, Oliver T, Mai V. Self-collected samples for testing of oncogenic human papillomavirus: a systematic review. JOGC 2007, 29:817-828.
22. Wikstrom I, Lindell M, Sanner K, Wilander E. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Canc 2011, 105:337-339.
23. Virtanen A, Nieminen P, Luostarinen T, Anttila A. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Canc Epidemiol Biomarkers Prev 2011, 20:1960-1969.
24. Virtanen A, Anttila A, Luostarinen T, Nieminen P. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Canc 2011, 128:2681-2687.
25. Szarewski A, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Edwards R, Lyons D, Walker J, Christison J, Frater A, Waller J. HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial. Br J Canc 2011, 104:915-920.
26. Rossi PG, Marsili LM, Camilloni L, Iossa A, Lattanzi A, Sani C, Di Pierro C, Grazzini G, Angeloni C, Capparucci P, Pekkegrini A, Schiboni ML, Sperati A, Confortini M, Bellanova C, D'Addetta A, Mania E, Visioli CB, Sereno E, Carozzi F. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Canc 2011, 104:248-254.
27. Gok M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, Voorhorst F, Belien JA, Babovic M, Snijders PJ, Meijer CJ. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010, 340:c1040. 10.1136/bmj.c1040, 2837143, 20223872.
28. Bais AG, van Kemenade FJ, Berkhof J, Verheijen RH, Snijders PJ, Voorhorst F, Babovic M, van Ballegooijen M, Helmerhorst TJ, Meijer CJ. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Canc 2007, 120:1505-1510.
29. Sancho-Garnier H, Tamalet C, Halfon P, Leandri FX, Retraite LL, Djoufelkit K, Heid P, Davies P, Piana L. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Canc 2013, 133:2681-2687.
30. Electoral Act 2002. :, [http://www.austlii.edu.au/cgi-bin/download.cgi/cgi-bin/download.cgi/download/au/legis/vic/consol_act/ea2002103.pdf].
31. Welfare AIoHa Cervical screening in Australia 2010-2011 2013, Canberra: Australian Institute of Health and Welfare, Welfare AIoHa.
32. Franco EL. Chapter 13: primary screening of cervical cancer with human papillomavirus tests. J Natl Canc Inst Monogr 2003, 31:89-96.
33. Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Canc Inst 2005, 97:1072-1079.
34. Stoler MH, Wright TC, Sharma A, Apple R, Gutekunst K, Wright TL. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol 2011, 135:468-475. 10.1309/AJCPZ5JY6FCVNMOT, 21350104.
35. Park Y, Lee E, Choi J, Jeong S, Kim HS. Comparison of the Abbott realtime high-risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid capture 2 assays to direct sequencing and genotyping of HPV DNA. J Clin Microbiol 2012, 50:2359-2365. 10.1128/JCM.00337-12, 3405569, 22518863.
36. Lindemann ML, Dominguez MJ, de Antonio JC, Sandri MT, Tricca A, Sideri M, Khiri H, Ravet S, Boyle S, Aldrich C, Halfon P. Analytical comparison of the cobas HPV test with Hybrid capture 2 for the detection of high-risk HPV genotypes. J Mol Diagn 2012, 14:65-70. 10.1016/j.jmoldx.2011.09.005, 22079749.
37. National Health and Medical Research Council Screening to Prevent Cervical Cancer: Guidelines for the Management of Asymptomatic Women with Screen Detected Abnormalities 2005, Canberra, Australia: Australian Government, National Health and Medical Research Council.
38. National cervical screening program renewal. [http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/ncsp-renewal].